Internal Medicine, Rheumatology · Champaign, IL
NPI
1831376961
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1701 Curtis Rd
Champaign, IL, 61822
Phone (217) 365-2851
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
947 services
Medicare patients, 2024
301
Average age 70
Drug cost, 2024
$3.7M
2,260 prescriptions
Company payments, 2025
$148
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Belal Said was code 99214 (office e&m - established), 232 times for 121 patients. In total Belal Said billed 947 services in 12 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 232 | 121 | $69.95 | $16K |
| 99214 Office E&M - Established | Office | 208 | 112 | $65.01 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 131 | 81 | $13.03 | $1,707 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 130 | 77 | $13.09 | $1,702 |
| 99213 Office E&M - Established | Facility | 42 | 35 | $44.87 | $1,884 |
| 99215 Office E&M - Established | Office | 41 | 26 | $95.05 | $3,897 |
| 99213 Office E&M - Established | Office | 24 | 20 | $47.89 | $1,149 |
| 99204 Office E&M - New | Facility | 22 | 22 | $106.61 | $2,345 |
| 99204 Office E&M - New | Office | 20 | 20 | $94.59 | $1,892 |
| 99215 Office E&M - Established | Facility | 19 | 16 | $93.91 | $1,784 |
| 99205 Office E&M - New | Facility | 14 | 14 | $141.35 | $1,979 |
| 20610 Joint Injection | Facility | 13 | 12 | $37.44 | $487 |
| 99205 Office E&M - New | Office | 12 | 12 | $98.53 | $1,182 |
By year: 2022 $38K for 630 services; 2023 $48K for 672 services; 2024 $51K for 947 services.
Medicare prescription drug claims, 2024
In 2024, the drug Belal Said prescribed most often to Medicare patients was Prednisone, with 259 prescriptions and refills. In total Belal Said wrote 2,260 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 259 | 510 | 90 | $2,212 |
| Methotrexate Methotrexate Sodium | 241 | 528 | 71 | $6,515 |
| Hydroxychloroquine Sulfate Generic | 202 | 537 | 65 | $6,635 |
| Tramadol Hcl Generic | 135 | 141 | 27 | $906 |
| Leflunomide Generic | 132 | 293 | 35 | $6,383 |
| Alendronate Sodium Generic | 126 | 328 | 43 | $940 |
| Enbrel Sureclick Etanercept | 113 | 135 | 19 | $1.0M |
| Humira(Cf) Pen Adalimumab | 101 | 111 | 15 | $720K |
| Actemra Actpen Tocilizumab | 66 | 80 | Under 11 | $381K |
| Gabapentin Generic | 53 | 153 | 18 | $856 |
| Allopurinol Generic | 53 | 148 | 12 | $453 |
| Celecoxib Generic | 51 | 116 | 19 | $2,579 |
| Methylprednisolone Generic | 47 | 48 | 37 | $243 |
| Rinvoq Upadacitinib | 46 | 50 | Under 11 | $307K |
| Mycophenolate Mofetil Generic | 36 | 67 | Under 11 | $9,162 |
Brand drugs: - claims; generic drugs: 1,699 claims; opioid claims: 164.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Belal Said $148 ($148 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $125.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $125 |
| Recor Medical Inc | 1 | $23.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.